The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)


TAVI in patients with reduced life expectancy

EuroIntervention 2020;16:794-796. DOI: 10.4244/EIJV16I10A148

1. Centre for Cardiovascular Medicine and Devices, William Harvey Research Institute, Queen Mary University of London, London, United Kingdom; 2. Barts Heart Centre, St. Bartholomew’s Hospital, London, United Kingdom; 3. Yale University School of Medicine, New Haven, CT, USA; 4. Institute of Cardiovascular Sciences, University College London, London, United Kingdom

We are frequently confronted with a request to consider valve implantation in patients who will not live to see a clear overall improvement of their prognosis. The decision to withhold interventional treatment often does not come easily and should be made following ethically informed protocols and guidance.

We will review the various patient groups with reduced life expectancy, highlight the recommended decision pathways, refer to the available experience and guidelines, and discuss the management choices for this difficult cohort of patients.

Patient groups with limited life expectancy

Many patients presenting to the heart valve service ...

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

Read next article
PCR Planet: a review of structural transcatheter intervention practice across the continents